Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Spiotto

Showing results (11-20 of 72) with videos related to

Pageof 8
Sort By:
Advances in Experimental Medicine and Biology|December 7, 2020
Correction to: Notch Signaling and Human Papillomavirus-Associated Oral TumorigenesisTrinath Das, Rong Zhong, Michael T Spiotto
Current Opinion in Immunology|November 25, 2003
Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturationMichael T Spiotto, Yang-Xin Fu, Hans Schreiber
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Genetic changes occurring in established tumors rapidly stimulate new antibody responsesMichael T Spiotto, Michael A Reth, Hans Schreiber
Nature Medicine|February 26, 2004
Bystander elimination of antigen loss variants in established tumorsMichael T Spiotto, Donald A Rowley, Hans Schreiber
International Journal of Radiation Oncology, Biology, Physics|April 27, 2007
Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patientsMichael T Spiotto, Steven L Hancock, Christopher R King
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomyChristopher R King, Michael T Spiotto, Daniel S Kapp
The Laryngoscope|September 8, 2015
Predictors and outcomes for chronic tracheostomy after chemoradiation for advanced laryngohypopharyngeal cancerGina D Jefferson, Barry L Wenig, Michael T Spiotto
Anti-Cancer Drugs|December 9, 2014
Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancerMichael T Spiotto, Hongyuan Cao, Loren Mell, et al.
Frontiers in Immunology|February 14, 2022
Genetic Changes Driving Immunosuppressive Microenvironments in Oral PremalignancyRoberto Rangel, Curtis R Pickering, Andrew G Sikora, et al.
Head & Neck|April 8, 2022
Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysisMark C Korpics, William Tyler Turchan, Matthew Koshy, et al.
Pageof 8

Showing results (11-20 of 72) with videos related to

Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|December 7, 2020
Correction to: Notch Signaling and Human Papillomavirus-Associated Oral TumorigenesisTrinath Das, Rong Zhong, Michael T Spiotto
Current Opinion in Immunology|November 25, 2003
Tumor immunity meets autoimmunity: antigen levels and dendritic cell maturationMichael T Spiotto, Yang-Xin Fu, Hans Schreiber
Proceedings of the National Academy of Sciences of the United States of America|April 19, 2003
Genetic changes occurring in established tumors rapidly stimulate new antibody responsesMichael T Spiotto, Michael A Reth, Hans Schreiber
Nature Medicine|February 26, 2004
Bystander elimination of antigen loss variants in established tumorsMichael T Spiotto, Donald A Rowley, Hans Schreiber
International Journal of Radiation Oncology, Biology, Physics|April 27, 2007
Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patientsMichael T Spiotto, Steven L Hancock, Christopher R King
International Journal of Radiation Oncology, Biology, Physics|August 19, 2008
Obesity and risk of biochemical failure for patients receiving salvage radiotherapy after prostatectomyChristopher R King, Michael T Spiotto, Daniel S Kapp
The Laryngoscope|September 8, 2015
Predictors and outcomes for chronic tracheostomy after chemoradiation for advanced laryngohypopharyngeal cancerGina D Jefferson, Barry L Wenig, Michael T Spiotto
Anti-Cancer Drugs|December 9, 2014
Angiotensin-converting enzyme inhibitors predict acute kidney injury during chemoradiation for head and neck cancerMichael T Spiotto, Hongyuan Cao, Loren Mell, et al.
Frontiers in Immunology|February 14, 2022
Genetic Changes Driving Immunosuppressive Microenvironments in Oral PremalignancyRoberto Rangel, Curtis R Pickering, Andrew G Sikora, et al.
Head & Neck|April 8, 2022
Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysisMark C Korpics, William Tyler Turchan, Matthew Koshy, et al.
Pageof 8